Source link : https://www.newshealth.biz/health-news/high-response-rate-in-heavily-treated-multiple-myeloma-with-novel-drug-combination/
A novel combination for relapsed/refractory multiple myeloma produced responses in about 80% of a heavily treated population, albeit with a high incidence of hematologic toxicity and infections. The 94-patient cohort had an overall response rate (ORR) of 78% across a range of doses of talquetamab (Talvey) and teclistamab (Tecvayli), including 80% of patients treated with […]
Author : News Health
Publish date : 2025-01-08 22:22:30
Copyright for syndicated content belongs to the linked Source.